Melanoma cell expression of fas(Apo-1/CD95) ligand: implications for tumor immune escape

被引：0
|
作者：
机构：
来源：
Science | / 5291卷 / 1363期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Alterations of Fas (Apo-1/CD95) gene in cutaneous malignant melanoma
    Shin, MS
    Park, WS
    Kim, SY
    Kim, HS
    Kang, SJ
    Song, KY
    Park, JY
    Dong, SM
    Pi, JH
    Oh, RR
    Lee, JY
    Yoo, NJ
    Lee, SH
    AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (06): : 1785 - 1791
  • [32] Alterations of Fas (Apo-1/CD95) gene in cutaneous malignant melanoma
    Lee, SH
    Shin, MS
    Park, WS
    Lee, JY
    Yoo, NJ
    JOURNAL OF PATHOLOGY, 1999, 189 : 27A - 27A
  • [33] Regulation of apoptosis through CD95 (APO-1/FAS) receptor/ligand
    Debatin, KM
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 228 - 228
  • [34] CD95(APO-1/Fas) receptor and ligand: Their role in T-cell deletion
    Krammer, PH
    IMMUNE TOLERANCE: INTERNATIONAL SYMPOSIUM ON IMMUNE TOLERANCE, 1996, : 155 - 158
  • [35] Expression of Fas (CD95/APO-1) and Fas ligand in lung cancer, its prognostic and predictive relevance
    Koomägi, R
    Volm, M
    INTERNATIONAL JOURNAL OF CANCER, 1999, 84 (03) : 239 - 243
  • [36] Expression of Fas (CD95/APO-1) and Fas Ligand (FasL) in Experimentally-Induced Acute Pancreatitis
    Pardalis, Vassilios
    Palli, Eleni
    Lambropoulou, Maria
    Tsigalou, Christina
    Anagnostoulis, Stavros
    Garoufalis, Grigorios
    Bolanaki, Helen
    Simopoulos, Constantinos
    Karayiannakis, Anastasios J.
    JOURNAL OF INVESTIGATIVE SURGERY, 2014, 27 (02) : 65 - 72
  • [37] Regulation of Fas (APO-1, CD95) and Fas ligand expression in leukocytes during systemic inflammation in humans
    Marsik, C
    Halama, T
    Cardona, F
    Wlassits, W
    Mayr, F
    Pleiner, J
    Jilma, B
    SHOCK, 2003, 20 (06): : 493 - 496
  • [38] Resistance to Fas (APO-1/CD95)-mediated apoptosis and expression of Fas ligand in esophageal cancer: the Fas counterattack
    O'Connell, J
    Bennett, MW
    O'Sullivan, GC
    Collins, JK
    Shanahan, F
    DISEASES OF THE ESOPHAGUS, 1999, 12 (02): : 83 - 89
  • [39] Expression of Fas (APO-1/CD95) and Fas ligand in astrocytic brain tumors and the mechanisms of necrogenesis in glioblastomas
    Ohgaki, H
    Gratas, C
    Tohma, Y
    Tachibana, O
    Kleihues, P
    BRAIN PATHOLOGY, 1997, 7 (04) : 1183 - 1183
  • [40] The CD95(APO-1/Fas)/CD95L system
    Krammer, PH
    TOXICOLOGY LETTERS, 1998, 103 : 131 - 137
12345